JP2004538237A - 表面アレルゲンに対するアレルギー反応を減少させるための方法および組成物 - Google Patents
表面アレルゲンに対するアレルギー反応を減少させるための方法および組成物 Download PDFInfo
- Publication number
- JP2004538237A JP2004538237A JP2000587803A JP2000587803A JP2004538237A JP 2004538237 A JP2004538237 A JP 2004538237A JP 2000587803 A JP2000587803 A JP 2000587803A JP 2000587803 A JP2000587803 A JP 2000587803A JP 2004538237 A JP2004538237 A JP 2004538237A
- Authority
- JP
- Japan
- Prior art keywords
- allergen
- ige
- reagent
- binds
- epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000013566 allergen Substances 0.000 title claims abstract description 68
- 206010020751 Hypersensitivity Diseases 0.000 title claims description 22
- 238000000034 method Methods 0.000 title claims description 22
- 239000000203 mixture Substances 0.000 title claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 30
- 230000000873 masking effect Effects 0.000 claims abstract description 26
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 229920000126 latex Polymers 0.000 claims abstract description 22
- 208000026935 allergic disease Diseases 0.000 claims abstract description 21
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 13
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims abstract description 11
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims description 47
- 239000000126 substance Substances 0.000 claims description 27
- 241001465754 Metazoa Species 0.000 claims description 15
- 239000004816 latex Substances 0.000 claims description 11
- 238000012216 screening Methods 0.000 claims description 7
- 210000003491 skin Anatomy 0.000 claims description 7
- 210000003630 histaminocyte Anatomy 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 claims description 4
- 108020003175 receptors Proteins 0.000 claims description 4
- 102000005962 receptors Human genes 0.000 claims description 4
- 231100000331 toxic Toxicity 0.000 claims description 4
- 230000002588 toxic effect Effects 0.000 claims description 4
- 102000009438 IgE Receptors Human genes 0.000 claims description 2
- 108010073816 IgE Receptors Proteins 0.000 claims description 2
- 208000030961 allergic reaction Diseases 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 108010060231 Insect Proteins Proteins 0.000 claims 1
- 101000952180 Morus alba Mulatexin Proteins 0.000 claims 1
- 239000002085 irritant Substances 0.000 claims 1
- 231100000021 irritant Toxicity 0.000 claims 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 abstract description 28
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 abstract description 28
- 239000000427 antigen Substances 0.000 abstract description 25
- 108091007433 antigens Proteins 0.000 abstract description 25
- 102000036639 antigens Human genes 0.000 abstract description 25
- 208000024891 symptom Diseases 0.000 abstract description 9
- 230000000172 allergic effect Effects 0.000 abstract description 6
- 208000010668 atopic eczema Diseases 0.000 abstract description 6
- 108020004635 Complementary DNA Proteins 0.000 abstract description 5
- 230000002009 allergenic effect Effects 0.000 abstract description 4
- 241000282324 Felis Species 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 22
- 229960004784 allergens Drugs 0.000 description 16
- 230000007815 allergy Effects 0.000 description 12
- 238000010561 standard procedure Methods 0.000 description 10
- 230000000903 blocking effect Effects 0.000 description 9
- 239000011347 resin Substances 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 150000001413 amino acids Chemical group 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 7
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 241000238631 Hexapoda Species 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 239000002981 blocking agent Substances 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 238000009169 immunotherapy Methods 0.000 description 5
- 241000238876 Acari Species 0.000 description 4
- 241000282326 Felis catus Species 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000011031 large-scale manufacturing process Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000258242 Siphonaptera Species 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241001674044 Blattodea Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 101800002189 Hevein Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000257303 Hymenoptera Species 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- 101710194991 Pro-hevein Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WKMZPSWMEXVKKG-XITFREQTSA-N hevein Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CS)C(=O)NCC(=O)OC(=O)CC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CNC2=CC=CC=C12 WKMZPSWMEXVKKG-XITFREQTSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 238000004091 panning Methods 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 238000002823 phage display Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 101800000263 Acidic protein Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011686 Cutaneous vasculitis Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101800001224 Disintegrin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 241000724791 Filamentous phage Species 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 108700039992 Hevea brasiliensis Hev b 6.01 Proteins 0.000 description 1
- 101500003018 Hevea brasiliensis Hevein Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 208000009481 Laryngeal Edema Diseases 0.000 description 1
- 206010023845 Laryngeal oedema Diseases 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229940074608 allergen extract Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 229940124581 decongestants Drugs 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940046528 grass pollen Drugs 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000008348 humoral response Effects 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 231100001039 immunological change Toxicity 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- XMBWDFGMSWQBCA-RNFDNDRNSA-M iodine-131(1-) Chemical compound [131I-] XMBWDFGMSWQBCA-RNFDNDRNSA-M 0.000 description 1
- 208000001875 irritant dermatitis Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
- 230000036967 uncompetitive effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21611798A | 1998-12-18 | 1998-12-18 | |
| PCT/US1999/030238 WO2000035484A2 (en) | 1998-12-18 | 1999-12-17 | Methods and compositions for decreasing allergic reactions to surface allergens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004538237A true JP2004538237A (ja) | 2004-12-24 |
| JP2004538237A5 JP2004538237A5 (enExample) | 2005-03-17 |
Family
ID=22805772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000587803A Withdrawn JP2004538237A (ja) | 1998-12-18 | 1999-12-17 | 表面アレルゲンに対するアレルギー反応を減少させるための方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20010051155A1 (enExample) |
| EP (1) | EP1140169A2 (enExample) |
| JP (1) | JP2004538237A (enExample) |
| AU (1) | AU2196500A (enExample) |
| CA (1) | CA2355650A1 (enExample) |
| WO (1) | WO2000035484A2 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010533179A (ja) * | 2007-07-09 | 2010-10-21 | ネステク ソシエテ アノニム | 環境アレルゲンによって引き起こされるアレルギーを軽減する方法 |
| US9388236B2 (en) | 2007-07-09 | 2016-07-12 | Nestec Sa | Methods for reducing allergies caused by environmental allergens |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020019009A1 (en) * | 1999-12-09 | 2002-02-14 | Roggen Erwin Ludo | High throughput screening (HTS) assays |
| US7060687B2 (en) | 2001-02-07 | 2006-06-13 | Genmont Biotechnology Co. | Live vaccines for allergy treatment |
| US20020197268A1 (en) * | 2001-06-08 | 2002-12-26 | Hsu Ching-Hsaing | Allergen-containing milk for allergy treatment |
| JP3642340B2 (ja) * | 2003-03-28 | 2005-04-27 | ダイキン工業株式会社 | 有害物質除去方法、並びに、それに用いる空気浄化用フィルタ、拭き取りシートなどの有害物質除去材、及び、その保管方法 |
| EP2022507A1 (en) * | 2007-08-07 | 2009-02-11 | Universität Hamburg | Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy |
| US8962241B2 (en) * | 2010-07-20 | 2015-02-24 | California Institute Of Technology | Triggered molecular geometry based bioimaging probes |
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| EP3760223A1 (en) | 2013-04-03 | 2021-01-06 | N-Fold Llc | Nanoparticle composition for desensitizing a subject to peanut allergens |
| EP3631464A1 (en) * | 2017-05-25 | 2020-04-08 | Société des Produits Nestlé S.A. | Methods for enabling pet ownership |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5512283A (en) * | 1990-07-06 | 1996-04-30 | Allergene, Inc. | Methods for the selective suppression of an immune response to dust mite der Pi |
| JPH08501799A (ja) * | 1992-12-21 | 1996-02-27 | タノックス バイオシステムズ インコーポレイテッド | アレルゲン特異的ＩｇＡモノクローナル抗体及びアレルギー治療のための関連物質 |
| WO1995012420A1 (en) * | 1993-11-04 | 1995-05-11 | Bsi Corporation | Barrier coatings for surfaces |
-
1999
- 1999-12-17 JP JP2000587803A patent/JP2004538237A/ja not_active Withdrawn
- 1999-12-17 WO PCT/US1999/030238 patent/WO2000035484A2/en not_active Ceased
- 1999-12-17 EP EP99966427A patent/EP1140169A2/en not_active Withdrawn
- 1999-12-17 AU AU21965/00A patent/AU2196500A/en not_active Abandoned
- 1999-12-17 CA CA002355650A patent/CA2355650A1/en not_active Abandoned
-
2001
- 2001-07-02 US US09/897,864 patent/US20010051155A1/en not_active Abandoned
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010533179A (ja) * | 2007-07-09 | 2010-10-21 | ネステク ソシエテ アノニム | 環境アレルゲンによって引き起こされるアレルギーを軽減する方法 |
| US9388236B2 (en) | 2007-07-09 | 2016-07-12 | Nestec Sa | Methods for reducing allergies caused by environmental allergens |
| JP2017002059A (ja) * | 2007-07-09 | 2017-01-05 | ネステク ソシエテ アノニム | 環境アレルゲンによって引き起こされるアレルギーを軽減する方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2196500A (en) | 2000-07-03 |
| CA2355650A1 (en) | 2000-06-22 |
| WO2000035484A3 (en) | 2000-10-19 |
| EP1140169A2 (en) | 2001-10-10 |
| US20010051155A1 (en) | 2001-12-13 |
| WO2000035484A2 (en) | 2000-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6891205B2 (ja) | 経口脱感作のための落花生処方物の製造 | |
| DE69931377T2 (de) | Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren | |
| Chan-Yeung et al. | Aetiological agents in occupational asthma | |
| US5670626A (en) | Allergen-specific human IgA monoclonal antibodies for mucosal administration | |
| TWI471565B (zh) | 鑑定過敏原性蛋白質和肽之方法 | |
| JP2002501748A (ja) | アレルギー反応を減少させるための方法および試薬 | |
| CN101745112A (zh) | TNFα相关疾病的治疗 | |
| JP2004538237A (ja) | 表面アレルゲンに対するアレルギー反応を減少させるための方法および組成物 | |
| Popescu et al. | Molecular diagnosis in cat allergy | |
| JP2004537991A (ja) | アレルギー及び喘息治療用Ｆｃε融合タンパク質 | |
| JP2004538237A5 (enExample) | ||
| Pramod | Immunological basis for the development of allergic diseases-prevalence, diagnosis and treatment strategies | |
| JP6073239B2 (ja) | 抗原隠蔽剤としての使用のための、ヒトラクトフェリン誘導ペプチド | |
| Katial | Cockroach allergy | |
| Prodić et al. | The influence of environmental pollution on the allergenic potential of grass pollen | |
| Sevcik et al. | On the presence of antibodies against bovine, equine and poultry immunoglobulins in human IgG preparations, and its implications on antivenom production | |
| Özdemir | Cockroach allergy, respiratory allergic diseases and its immunotherapy | |
| Yang et al. | Allergen Preparation in AIT, Now and in the Future | |
| Corthésy et al. | Efficacy of a therapeutic treatment using gas‐filled microbubble‐associated phospholipase A2 in a mouse model of honeybee venom allergy | |
| EP0714662A1 (en) | Antiallergic agent | |
| Jensen-Jarolim et al. | Allergic and atopic eczema in humans and their animals | |
| JP2006340658A (ja) | 多糖修飾によるアレルゲンタンパク質の抗原構造の被覆により免疫抑制効果を有する食品組成物 | |
| SHARMA et al. | PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST INDIAN PAPER WASP ROPALIDIA MARGINATA VENOM TOXINS AND THEIR EFFICACY IN THE REVERSAL OF TOXIC EFFECTS | |
| Helm et al. | Protein and cell engineering of components of the human immunoglobulin E receptor/effector system: applications for therapy and diagnosis | |
| Gepp | Investigation of antibody responses of birch pollen allergic individuals by using chimeric allergens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20070306 |